Global Active Pharmaceutical Ingredients (API) Market

Global Active Pharmaceutical Ingredients (API) Market, 2014 - 2020
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia Pacific
Rest of the World (RoW)
Market Bytes:
The global Active Pharmaceutical Ingredient (API) market is valued at US$ 127 Bn in 2014 and it is
projected to expand at a healthy CAGR during the forecast period.
By API types, the biological API market segment is expected to have the highest growth rate of around
8% during the forecast period of 2015-2020. The biological API segment is valued at about 30% of the
global API market in 2014. It grew at an year on year growth rate of about 8% during 2015.
The global API market is transforming, as large pharmaceutical companies shift focus toward the
biological APIs segment. Over 100 different biologic therapeutic agents have been approved for use in the
U.S. and several more are awaiting marketing approval. The companies that used to rely solely on small
molecules (synthetic chemical API) for their revenue are now considering new avenues to maintain the
revenue stream due to generic influx. Protein-based therapeutics (peptides, proteins, enzymes and
antibodies) have emerged as a major growth engine in the biological API market. Large pharmaceutical
companies are scaling down their small molecule manufacturing facilities to focus on biologic drugs,
thereby presenting greater opportunities for contract manufacturing companies. The overall cost of drug
Persistence Market Research 5